New Report Casts Doubt On PhRMA Study

Law360, New York (August 1, 2006, 12:00 AM EDT) -- Still smarting from a study last month that lauded the competitive effects of authorized generics, the Generic Pharmaceutical Association is now touting a report of its own that calls into question the credibility of the earlier report.

On Monday, the GpHA showcased the results of an independent study that blasted an earlier analysis commissioned by the Pharmaceutical Research and Manufacturers of America.

"The nation’s generic drug companies will not allow PhRMA to pull the wool over consumers’ eyes,” said Kathleen Jaeger, president and CEO of GPhA....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.